A New Name in Weight-Loss Drugs

This podcast episode explores the expansion of Hims & Hers into the weight loss market by adding GLP-1 weight loss injections to their existing personalized subscription care offerings. The move has excited investors and resulted in a 30% increase in the stock. The episode also discusses the business model of Hims & Hers, the potential of the weight loss market and GLP-1s, and the growth of Wix after the COVID pandemic. It mentions the challenges faced by boutique fitness businesses, CEO turnover in the fitness industry, and a disturbing case of a CEO's threatening behavior. The episode concludes by mentioning investment opportunities in the fitness industry, such as Lululemon and Nike.